Condition

NUT Carcinoma (2)

Castrate Resistant Prostate Cancer (1)

Neoplasms (1)

Overall Status

Completed (1)

Not yet recruiting (1)

Sign in for free

Phase

phase 1 (2)

Sponsor

Boehringer Ingelheim (1)

Epigenetix, Inc. (1)

Collaborator

Intervention

bi 894999 (1)

ep31670 (1)

Study Documents

Intervention Type

drug (2)

Funder Type

Industry (2)

Study Type

Interventional (2)

nut carcinoma

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Castrate Resistant Prostate Cancer, NUT Carcinoma Trial (EP31670)

Not yet recruiting

Castrate Resistant Prostate Cancer
NUT Carcinoma

EP31670

(no location specified)

Aug 3, 2022

Tumors, NUT Carcinoma Trial in Worldwide (BI 894999)

Completed

Neoplasms
NUT Carcinoma

BI 894999

Boston, Massachusetts
+15 more

Dec 3, 2021